These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20956720)

  • 1. Improvements to the newborn bloodspot screening service are required to meet national standards.
    Bello S; Ferguson C; Wallis R
    J Med Screen; 2010; 17(3):114-20. PubMed ID: 20956720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neonatal screening for metabolic diseases: need for efficacy studies].
    Williams M
    Ned Tijdschr Geneeskd; 2008 Jul; 152(30):1653-6. PubMed ID: 18714517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
    Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
    Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sweet and sour aspects of medium-chain acyl CoA dehydrogenase deficiency. Commentary on K. Yusuf et al.: Neonatal ventricular tachyarrhythmias in medium chain acyl-CoA dehydrogenase deficiency (Neonatology 2010;98:260-264).
    Derks TG
    Neonatology; 2010; 98(3):265-7. PubMed ID: 20414004
    [No Abstract]   [Full Text] [Related]  

  • 6. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK.
    Goddard P
    J Fam Health Care; 2004; 14(4):90-2. PubMed ID: 15453442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neonatal death due to medium-chain acyl-CoA dehydrogenase deficiency: utilization of the neonatal metabolic screen in a functional approach to sudden unexplained infant death.
    Manoukian AA; Ha CE; Seaver LH; Bhagavan NV
    Am J Forensic Med Pathol; 2009 Sep; 30(3):284-6. PubMed ID: 19696588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
    Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
    J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabonomics of newborn screening dried blood spot samples: a novel approach in the screening and diagnostics of inborn errors of metabolism.
    Dénes J; Szabó E; Robinette SL; Szatmári I; Szőnyi L; Kreuder JG; Rauterberg EW; Takáts Z
    Anal Chem; 2012 Nov; 84(22):10113-20. PubMed ID: 23094949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neonatal screening in France].
    Briard ML; Farriaux JP
    Soins Gynecol Obstet Pueric Pediatr; 1990 Mar; (106):37-41. PubMed ID: 2360140
    [No Abstract]   [Full Text] [Related]  

  • 11. Extended newborn screening: an update for the general paediatrician.
    Coman D; Bhattacharya K
    J Paediatr Child Health; 2012 Feb; 48(2):E68-72. PubMed ID: 22017206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands.
    van der Hilst CS; Derks TG; Reijngoud DJ; Smit GP; TenVergert EM
    J Pediatr; 2007 Aug; 151(2):115-20, 120.e1-3. PubMed ID: 17643759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe metabolic acidosis in a newborn with an abnormal newborn screen.
    Schrier SA; Ficicioglu C
    Clin Pediatr (Phila); 2012 May; 51(5):518-20. PubMed ID: 22500046
    [No Abstract]   [Full Text] [Related]  

  • 14. Healthcare use and costs of medium-chain acyl-CoA dehydrogenase deficiency in Australia: screening versus no screening.
    Haas M; Chaplin M; Joy P; Wiley V; Black C; Wilcken B
    J Pediatr; 2007 Aug; 151(2):121-6, 126.e1. PubMed ID: 17643760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Deficiency of the fatty-acid oxidising enzyme medium-chain acyl-CoA dehydrogenase (MCAD) in an adult, detected during a neonatal screening programme].
    Derks TG; Jakobs H; Gerding A; Niezen-Koning KE; Reijngoud DJ; Smit GP
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2185-90. PubMed ID: 15559414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal screening in Europe; the situation in 2004.
    Loeber JG
    J Inherit Metab Dis; 2007 Aug; 30(4):430-8. PubMed ID: 17616847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal ventricular tachyarrhythmias in medium chain acyl-CoA dehydrogenase deficiency.
    Yusuf K; Jirapradittha J; Amin HJ; Yu W; Hasan SU
    Neonatology; 2010; 98(3):260-4. PubMed ID: 20414003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for inborn errors of metabolism in Beijing, China: 22 years of experience.
    Tu WJ; Cai J; Shi XD
    J Med Screen; 2011; 18(4):213-4. PubMed ID: 22184735
    [No Abstract]   [Full Text] [Related]  

  • 19. Neonatal screening for biochemical disorders.
    Holton JB
    Br J Hosp Med; 1988 Apr; 39(4):317-9, 322-4. PubMed ID: 3164641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target Diseases for Neonatal Screening in Germany.
    Spiekerkoetter U; Krude H
    Dtsch Arztebl Int; 2022 Apr; 119(17):306-316. PubMed ID: 35140012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.